Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s diseaseWei‐Ming Su(Sichuan University), Yong‐Ping Chen(Sichuan University)Journal of Neurology Neurosurgery & PsychiatryJune 22, 202310.1136/jnnp-2023-331142Cited by 150SaveCiteExport RISWatch citationsRelated PapersTBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro|BMC Medicine|2024|39